6533b872fe1ef96bd12d3762

RESEARCH PRODUCT

TCT-34 Prediction of acute kidney injury after TAVR by new biomarkers

Won KimGiovanni FilardoLuise GaedeMaren WeferlingKarl J. LacknerMirko DossThomas WaltherJohannes BlumensteinMani ArsalanMatthias RenkerHelge MöllmannChristian W. HammChristoph LiebetrauArnaud Van Linden

subject

medicine.medical_specialtyCreatinineTranscatheter aorticurogenital systembusiness.industrymedicine.medical_treatmentAcute kidney injurymedicine.diseasechemistry.chemical_compoundValve replacementchemistryInternal medicinemedicineCardiologyKidney injuryCardiology and Cardiovascular MedicinebusinessComplication

description

Acute kidney injury (AKI) is a common complication after transcatheter aortic valve replacement (TAVR) and is associated with increased morbidity and mortality. Routinely used biomarkers such as creatinine show a diagnostic gap in the first hours after kidney injury. Thus, new biomarkers for earlier

https://doi.org/10.1016/j.jacc.2017.09.080